Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Top advances of the year: Radiopharmaceutical therapy for prostate cancer.
Journal: Cancer
Published: May 30, 2026
A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy.
Journal: AJNR. American journal of neuroradiology
Published: February 14, 2026
Stereotactic Body Radiation Therapy (SBRT)-Induced 68 Ga-PSMA PET Bone Flare.
Journal: Clinical nuclear medicine
Published: December 17, 2025
Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: February 14, 2025
Advances in PSMA-Targeted Radionuclide Therapeutics.
Journal: Current treatment options in oncology
Published: January 29, 2025
Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons.
Journal: Journal of imaging
Published: December 27, 2024
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.
Journal: The Prostate
Published: August 26, 2024
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 03, 2023
Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men.
Journal: Scientific reports
Published: August 10, 2022
Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial.
Journal: Translational oncology
Published: May 25, 2022
Last Updated: 09/26/2026